Change in names of Goalwise recommended Mutual Funds for 2018


Pursuant to SEBI mandated Recategorisation and Rationalisation of Mutual Funds there have been a lot of changes recently in Mutual Fund offerings of various fund houses.

Some funds have been stopped or merged into other funds in order to comply with SEBI's one category-one fund rule while for a lot of other funds, names and categories have been changed.

Amongst Goalwise recommended funds for 2018, there have been no mergers or closing of funds but quite a few of them now have new names to better reflect their category.


Old Name Old Category New Name New Category
Mirae Asset India Opportunities Fund Equity - Large Cap Mirae Asset India Equity Fund - Growth Equity - Large Cap
Invesco India Growth Fund Equity - Large Cap Invesco India Growth Opportunities Fund - Growth Equity - Large Cap
Principal Growth Fund Equity - Multi Cap Principal Multicap Growth Fund - Growth Equity - Multi Cap
Motilal Oswal MOSt Focused Multicap 35 Equity - Multi Cap Motilal Oswal Multicap 35 Fund - Growth Equity - Multi Cap
Aditya Birla Sun Life Small & Mid Cap Fund Equity - Small & Mid Cap* Aditya Birla Sun Life Small Cap Fund - Growth Small Cap*
L&T Emerging Business Fund Equity - Small & Mid Cap* L&T Emerging Business Fund Small Cap*
Reliance Medium Term Fund Debt - Short Term Reliance Prime Debt Fund - Growth Debt - Short Term
Birla Sun Life Short Term Fund Debt - Short Term Aditya Birla Sun Life Corporate Bond Fund - Growth Debt - Short Term
Kotak Treasury Advantage Fund Regular Plan - Growth Debt - Ultra Short Term Kotak Savings Fund Debt - Ultra Short Term
IDFC Ultra Short Term Fund Regular Plan - Growth Debt - Ultra Short Term IDFC Low Duration Fund Regular Plan - Growth Debt - Low Duration

There have also been changes in category for 2 funds which changed category from Small & Mid cap to Small Cap funds although their portfolios still have an almost equal allocation to Mid and small caps so we continue to hold them.

As of now, there are no changes in our recommendations and most probably we will follow our regular schedule of new recommendations in January only.